Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | CPB1 | P15086 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | PREP | P48147 | 2/20 | 0.47 |
| ▸ | CTSK | P43235 | 2/20 | 0.46 |
| ▸ | TLR4 | O00206 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18584576 | 0.77 | CPB1 (0.57) | ALDH1A1GAACPB1TSHRCTSK | |
| SCHEMBL18904843 | 0.77 | ALDH1A1 (0.64) | NAAAALDH1A1GAACPB1TSHR | |
| SCHEMBL18584577 | 0.77 | CPB1 (0.57) | ALDH1A1GAACPB1TSHRCTSK | |
| SCHEMBL17207725 | 0.76 | ALDH1A1 (0.59) | NAAAALDH1A1GAACPB1TSHR | |
| SCHEMBL425375 | 0.75 | ALDH1A1 (0.58) | NAAAALDH1A1GAACPB1TSHR | |
| SCHEMBL13421874 | 0.75 | ALDH1A1 (0.61) | NAAAALDH1A1GAACPB1TSHR | |
| SCHEMBL13421862 | 0.75 | ALDH1A1 (0.61) | NAAAALDH1A1GAACPB1TSHR | |
| SCHEMBL753991 | 0.74 | ALDH1A1 (0.57) | NAAAALDH1A1GAATSHREPHX1 | |
| SCHEMBL4079431 | 0.74 | NAAA (0.85) | NAAA | |
| SCHEMBL14286451 | 0.74 | ALDH1A1 (0.53) | NAAAALDH1A1GAACPB1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2772088-B2 | — | — | 1998-07-02 | — | — | JP | claimed |
| EP-0413762-A4 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | — | 1992-01-15 | — | — | EP | claimed |
| EP-0413762-A1 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | IGEN, INCORPORATED (US) | 1991-02-27 | — | — | EP | claimed |
| WO-1989010961-A1 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | IGEN, INC. (US) | 1989-11-16 | — | — | WO | claimed |
| EP-0413762-B1 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | IGEN INT INC (US) | 2000-07-12 | — | — | EP | disclosed |
| EP-0413762-A4 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | — | 1992-01-15 | — | — | EP | disclosed |
| EP-0413762-A1 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | IGEN, INCORPORATED (US) | 1991-02-27 | — | — | EP | disclosed |
| WO-1989010961-A1 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | IGEN, INC. (US) | 1989-11-16 | — | — | WO | disclosed |